Grace Therapeutics, Inc. (GRCE) income statement
GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.73+0.00 (0.00%)
Close on Nov 19, 2026Market cap $36.39MP/E –Yield –
Grace Therapeutics, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- -11.9%
Financial strength
- Current ratio
- 11.47
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 1100.5%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.75
- Dividend yield
- –
See a number that looks wrong?